StemCell Institute Inc.
StemCell Institute Inc. scores highest on Earnings (65) and lowest on Price (17). Its PosiPenta is 41.69 out of 100, around the middle of similar companies.
On the Penta Grid this week, StemCell Institute Inc. is Grid #53 of 91 in the Healthcare sector in Japan, and Grid #985 of 1,383 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| StemCell Institute Inc. | 41.69 | 17 | 65 | 41 | 44 | 42 |
| Cosmo Bio Company,Limited | 58.42 | 62 | 55 | 60 | 57 | 58 |
| Nano Holdings, Inc. | 19.65 | 20 | 13 | 13 | 27 | 25 |
| Carna Biosciences, Inc. | 27.79 | 0 | 45 | 53 | 4 | 37 |
| Kidswell Bio Corporation | 24.69 | 8 | 55 | 20 | 16 | 24 |
| Tsubota Laboratory Incorporated | 22.33 | 3 | 15 | 23 | 35 | 35 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 48.25 |
| P/B ratio | 2.65 |
EEarnings
| Trailing EPS | ₹8.95 |
| Forward EPS | ₹45.98 |
NNitro
| Price | 432.01 |
| 52-week high | 589.70 |
| 52-week low | 378.84 |
| Fall from 52-week high | 26.7% |
TTorque
| Return on equity (ROE) | 4.59% |
| Debt-to-equity | 0.19 |
AAnchor
| Beta (price swings) | 0.64 |
| Market cap | ₹435 Cr |
| Insider holding | 75.60% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is StemCell Institute Inc.'s PosiPenta score?
StemCell Institute Inc.'s PosiPenta is 41.69 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does StemCell Institute Inc. stand on the Penta Grid?
On the Penta Grid this week, StemCell Institute Inc. is Grid #53 of 91 in the Healthcare sector in Japan, and Grid #985 of 1,383 in Japan.
Which PosiPenta pillar is strongest for StemCell Institute Inc.?
Earnings (growth), with a score of 65 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for StemCell Institute Inc.?
Price (valuation), with a score of 17 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.